- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by MEI Pharma, Inc.
Total 2475 results
-
Astellas Pharma IncCompletedKidney TransplantationNetherlands
-
Akros Pharma Inc.CompletedAnemia of Chronic Kidney DiseaseUnited States
-
Astellas Pharma IncCompletedTransplantationNetherlands, Spain, Germany, United Kingdom, Poland, France
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1585United States
-
Antares Pharma Inc.CompletedRheumatoid Arthritis (RA)United States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronNetherlands
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Antares Pharma Inc.CompletedRheumatoid ArthritisUnited States
-
Astellas Pharma IncCompletedKidney TransplantationUnited States, Canada
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
gicare Pharma Inc.Completed
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Astellas Pharma IncCompleted
-
Akros Pharma Inc.Completed
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Telsar Pharma Inc.CompletedUlcerative ColitisUnited States
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.CompletedOsteoarthritisUnited States
-
Astellas Pharma IncCompletedCoronary Artery Disease | Kidney DiseasesUnited States
-
ZARS Pharma Inc.CompletedPostherpetic NeuralgiaUnited States
-
ZARS Pharma Inc.Suspended
-
ZARS Pharma Inc.CompletedShoulder Impingement SyndromeUnited States
-
ZARS Pharma Inc.CompletedPatellar TendinopathyUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetic of DigoxinFrance
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability of ASP015K | Pharmacokinetics of ASP015KUnited States
-
Trygg Pharma, Inc.UnknownSevere HypertriglyceridemiaUnited States
-
Akros Pharma Inc.CompletedHepatitis C Virus Infection, Response to Therapy ofPuerto Rico
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedA Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisChronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Cardiac RepolarizationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedLiver DiseaseUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP015K and MidazolamUnited States
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan, Taiwan, Thailand
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ValsartanJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan